Capital Advantage’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.53M Buy
45,749
+5,988
+15% +$580K 0.54% 36
2026
Q2
$4.07M Buy
39,761
+3,459
+10% +$326K 0.5% 36
2026
Q1
$2.86M Buy
36,302
+8,417
+30% +$677K 0.37% 42
2025
Q4
$2.03M Buy
27,885
+9,086
+48% +$644K 0.27% 47
2025
Q3
$1.27M Buy
18,799
+3,821
+26% +$247K 0.19% 51
2025
Q2
$946K Buy
+14,978
New +$872K 0.15% 63

Other funds holding EMXC

Capital Advantage's EMXC Position: Q3 2026 in Review

Capital Advantage increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 15% in Q3 2026, buying an estimated $580K and bringing the position to 45,749 shares worth $4.53M. The position accounts for 0.54% of the portfolio, ranked #36.

Capital Advantage first reported a position in EMXC in Q2 2025 and has held it in 6 quarters since. 310 funds tracked by Wall St. Rank hold EMXC as of Q3 2026.

  • Capital Advantage held 45,749 shares of iShares MSCI Emerging Markets ex China ETF worth $4.53M as of Q3 2026.
  • Capital Advantage bought 5,988 iShares MSCI Emerging Markets ex China ETF shares in Q3 2026, an estimated $580K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.54% of Capital Advantage's portfolio in Q3 2026, its #36 holding.
  • Capital Advantage first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2025 and has held it in 6 quarters since.
  • 310 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q3 2026.

Based on Capital Advantage's 13F filing for Q3 2026, filed 14 Oct 2026.